Neurotrophic Keratopathy Pre-survey
Thank you for participating in this brief pre-survey. Your valuable feedback will be used to help us identify future areas for education. All data will be de-identified and reported in aggregate.

After you complete this survey, please visit www.catalystmeded.com/NK to view the content and earn your CME credit.
Sign in to Google to save your progress. Learn more
Email *
How confident are you in your ability to diagnose neurotrophic keratopathy (NK)? *
Not confident
Very confident
How confident are you in your ability to appropriately use emerging treatments for NK? *
Not confident
Very confident
What stage of NK is characterized by friction from the eyelids resulting in fine or coarse punctate epithelial erosions of the cornea? *
Which of the following statements regarding early diagnosis of NK is LEAST ACCURATE? *
Which of the following statements regarding the use of cenegermin for treatment of NK is CORRECT? *
Which of the following statements regarding the safety and efficacy of available therapies for NK is CORRECT? *
Which of the following statements does NOT characterize appropriate management strategies for NK? *
A 66-year-old man with diabetes has a 2-year history of stage 1 NK. At his current visit, he reports experiencing reduced vision and discomfort in his right eye over the past few months that is associated with dry eye and difficulty reading. The patient tried artificial tears, topical steroids, and lubricating ointment previously. He has no history of ocular surgery or herpetic infection. Slit lamp examination reveals coarse punctate epithelial erosions and an epithelial defect with smooth, rolled edges which indicate stage 2 NK. Which of the following is the LEAST appropriate next step in managing his NK? *
A copy of your responses will be emailed to the address you provided.
Submit
Clear form
reCAPTCHA
This form was created inside of Catalyst Medical Education, LLC.. Report Abuse